The Term Breech Trial

Actual title: Planned cesarean section versus planned vaginal birth for breech presentation at term: a randomized multicenter trial

Background:

  • Who did the study, and who published it?

    • Another large collaborative group study – the Term Breech Trial Collaborative Group

      • Primary authors of the group based in Canada

      • Participating sites spanned Europe, Canada, Australia, Central/South America, Africa, Middle-East, India & Pakistan

      • Funded by Canadian Institutes of Health Research (like Canada’s NIH)

  • Why was the study done?

    • As we covered in our ECV and breech birth podcasts, breech presentation affects about 3-4% of term pregnancies.

    • At the time this was conducted (published in 2000), it was a controversial question for delivery approach:

      • Cohort studies prior to this trial suggested that cesarean section was potentially better.

        • However, these cohort studies were potentially confounded by inclusion of pregnancies that would not be considered for breech birth (i.e., footling presentation) or by lack of experience with breech deliveries by the participating physicians. 

      • Two smaller RCTs prior to this trial and a meta-analysis did not find any substantial benefit to planned cesarean.

    • Thus this ambitious trial was carried out to determine which was truly better.

  • What was the research question?

    • “To determine whether planned cesarean section was better than planned vaginal birth for selected fetuses in the breech presentation at term.” 

Methods:

  • Who participated and when?

    • Enrollment between Jan 1997 and April 2000 at 121 centers in 26 countries.

    • Eligibility:

      • Breech presentation at or after 37 weeks → assigned to planned cesarean or planned vaginal delivery after consent by telephone system.

      • If assigned to CD group: planned CD was scheduled for 38+ weeks.

        • If patient presented in labor, CD was performed as soon as possible.

        • Presentation was confirmed again prior to cesarean and if cephalic, vaginal birth was then planned.

      • If assigned to VD group: management was expectant until spontaneous labor began, unless an indication to induce labor or a different reason for cesarean developed.

        • Labor management protocol was standardized (a LOT of standards):

          • Induction and amniotomy were allowed for standard OB indications

          • FHR monitoring by intermittent auscultation or cEFM

          • Augmentation with oxytocin was permitted, “so long as the clinician was confident that there was no evidence of cephalopelvic disproportion.”

          • Adequate labor progress in 1st stage was 0.5cm/h after onset of active labor, and in 2nd stage was descent of breech to pelvic floor within 2hr of full dilation, and delivery being imminent within 1hr of active pushing.

            • If fetal heart rate abnormalities were encountered or lack of progress in labor occurred, CD was performed.

          • Anesthesia choice was left to patient and providers.

          • Delivery means was recommended to have no intervention until spontaneous exit of the infant to the umbilicus, and minimum intervention thereafter with no traction on the body; and controlled delivery of the head using forceps or Mariceau-Smellie-Veit maneuver. 

            • Total breech extraction was not permitted.

        • Deliveries were to be attended by an “experienced clinician” – defined as someone who considered themselves to be skilled and experienced at vaginal breech delivery and confirmed by their department head at their institution. 

          • Each clinician was assigned a code number prior to study enrollment and there was info recorded on their qualifications and years of experience with breech delivery. 

  • What were they looking for?

    • Primary outcome: perinatal or neonatal mortality at less than 28 days of age, or one or more serious neonatal morbidities such as:

      • Birth trauma, such as subdural hematoma, IVH, spinal cord injury, basal skull fracture, peripheral nerve injury, or clinically significant genital injury; 

      • Seizures at less than 24h of age or requiring 2+ drugs to control; 

      • Apgar of less than 4 at 5 mins

      • Cord base deficit of 15 or greater

      • Hypotonia for at least 2 hours

      • Stupor, decreased response to pain, or coma

      • Intubation and ventilation for at least 24h

      • Tube feeding for four days or more

      • NICU admission longer than 4 days

    • Secondary outcome: maternal mortality or serious maternal morbidity for up to six weeks postpartum, such as:

      • PPH > 1500 cc or need for transfusion

      • D&C for bleeding or retained tissue

      • Hysterectomy

      • Cervical laceration involving lower uterine segment (if SVD)

      • Vertical incision or serious hysterotomy extension (if CD)

      • Vulvar or perineal hematoma requiring evacuation

      • DVT / PE

      • Pneumonia, ARDS

      • Wound infection requiring prolonged hospital stay, wound breakdown

      • Bladder / ureter / bowel injury requiring repair, or development of fistula

      • Bowel obstruction

      • Other serious morbidities

    • They also used multiple logistic-regression analyses to test for interactions between demographic / baseline characteristics and outcomes:

      • I.e., looking at the perinatal outcomes for babies, looked at interaction with maternal age, parity, type of breech presentation, gestational age, labor vs induction, EFW by US vs Leopold’s, etc. 

    • They also looked at center’s standard of care in “usual care” vs “high standard of care” environments (as determined by a pre-study survey) and maternal/perinatal mortality rate in the center’s country

      • High standard of care was defined as:

        • Having ability to perform a cesarean within 10 mins (vs 60 mins)

        • Personnel to bag-mask a baby available immediately (vs 10 mins)

        • Personnel to intubate / provide PPV to baby within 10 mins (vs 30 mins)

        • Ability to ventilate a baby for >24h (vs need for transfer for this)

Results:

  • Who was recruited?

    • 2088 pregnant patients were randomized, with 1043 assigned to CD and 1045 assigned to VD

      • Maternal outcomes were available for 1041 (CD) and 1042 (VD) groups

      • Neonatal outcomes were available for 1039 (CD) and 1039 (VD) groups

        • Overall very low loss to follow up!

    • Groups were overall very similar:

      • 52% in each group were nulliparous

      • EFW > 3kg in ~66% in each group (with 60% in each group estimated by ultrasound)

        • 21.9% in each group underwent attempted ECV

      • 35% of deliveries in each arm took place in “high standard of care” centers.

      • ~42% in each group presented in labor, and ~23% in each group had membranes ruptured on presentation.

      • Median GA at delivery was similar in each group (39w3d CD vs 39w6d VD)

    • In the planned CD group:

      • 90% had a CD, and 10% had a VD

    • In the planned VD group:

      • 43.3% had a CD, and 56.7% had a VD

        • CDs most commonly performed for:

          • Fetopelvic disproportion or abnormal progress in labor (50.1%)

          • Fetal heart rate abnormality (28.6%)

          • Footling breech presentation (15.3%)

          • Patient request (13.5%)

          • Medical or OB complication (10%)

          • Cord prolapse (2.7%)

      • ~15% of labor was induced, and ~50% of labor was augmented.

        • Only 9% had a protocol violation of labor management:

          • 3.6% for prolonged labor

          • 1.4% for footling or uncertain presentation of breech at delivery

          • 2.7% had no experienced clinician at delivery 

  • Outcomes:

    • Primary

      • There was a significantly lower risk of perinatal/neonatal morbidity in the planned cesarean group:

        • 17/1039 (1.6%) CD vs 52/1039 (5.0%) VD (RR 0.33)

          • This held true in both countries with low perinatal mortality rates and high perinatal mortality rates.

          • This difference lessened (but remained statistically significant) with increasing experience of the attending provider – that is, there was less risk of morbidity when more experienced personnel were present.

          • This difference also lessened (but remained statistically significant) when excluding induced/augmented labor, deliveries without a skilled clinician, and those with footling/uncertain breech presentation 

            • Bottom line: there is higher perinatal morbidity with planned VD, despite increasingly optimal environments in subanalyses

      • There were 3 neonatal deaths in the cesarean group, and 13 in the vaginal delivery group.

        • One of the CD group deaths was actually a vaginal birth with difficult delivery.

        • Two of the vaginal birth deaths were likely prior to enrollment; two were of neonates discharged from the hospital in good condition otherwise; and two were suspected intrapartum demises before a cesarean section could be started.

      • The reduction in perinatal morbidity was much greater in countries with lower perinatal mortality rates, despite a higher likelihood of cesarean birth in the VD groups in those countries

        • I.e., in an area with low perinatal mortality and a higher likelihood to get cut intrapartum, the benefit of planned CD was even greater

      • There was more birth trauma, seizures, hypotonia, low Apgars, cord blood acidemia, need for mechanical ventilation, and longer NICU stays in the planned vaignal delivery group. 

      • Birth weight over 4000g was more likely in the VD group (5.8% vs 3.1%). 

    • Secondary

      • No major group differences in maternal morbidity/mortality. 

Impact

What was the impact of all of this, and what are we doing now?

  • Well you kind of know already – how many planned breech births have you done?

    • For most of us, that answer is probably 0 “planned” and maybe 1 or 2 “unplanned.”

  • This was absolutely a practice-changing paper – and has guided how we approach the patient with breech presentation at term ever since.

  • What criticisms exist of this trial?

    • High number of patients were randomized in labor, and questionable counseling:

      • ~42% in each arm – this begs the question about how “planned” each method actually was, and how much counseling or selectivity may have been realistically applied to each patient.

      • Can also see this in the higher rate of >4kg babies in the VD arm, as well as only 20% in each arm had an attempt at ECV. 

    • Standard of care was not consistent

      • Continuous EFM (for better or worse) was not standard

      • Fetal weight and attitude of the head, while recorded for trial data, did not have to be assessed by US

      • Generalizability is hard to interpret with the pooled results:

        • I.e., would you take your chances on a breech in Australia with a well-counseled patient with CTG in a place where you can do a C-section in under 10 minutes and have highly qualified neonatal staff immediately available? Or in another location where you can’t do a c-section even by 60 minutes? 

          • The subgroup analyses by perinatal mortality rate of countries tried to answer that, but it is curious they didn’t choose to divide it up by their “high standard” versus “usual standard” centers.

        • Subsequent analysis has shown that 30% of the morbidity/mortality in the VD group can be attributed to the 6.7% of vaginal deliveries attended by no experienced provider – also calling into question the impact of experience. 

    • Enrollment scheme:

      • Units would call to centralized location to get allocation and this was not stratified by center – theoretically, a highly experienced obstetrician could call and end up with randomization to cesarean each time, and likewise an inexperienced one could call and randomize to vaginal delivery each time.

    • Numerous protocol violations and enrollment questions

      • Included initially in the trial were: 2 demised infants, 2 sets of twins, an anencephalic baby, a baby with spina bidfida, and another baby with suspected anomalies. 

      • 2 of the vaginal delivery group deaths were suspected to have been prior to randomization, yet counted in the perinatal mortality. 

        • And a number of other deaths in the VD arm may not have been related to the delivery itself – i.e., SIDS, GI issues, anomalies, inadequate respiratory resuscitation or resources.

What about doing breech births? Can we? / should we?

  • We don’t recommend breech birth – that would be irresponsible to do outright!

  • Well counseled, well-selected patients in centers with experience in breech delivery, ability to perform cesarean, and provide immediate neonatal resuscitation – it may be reasonable, though this trial doesn’t totally answer that question based on problems with generalizability.

    • In the wake of this trial, the PREMODA study was performed in France and Belgium – a prospective observational study allowing providers to select mode of delivery where breech delivery was still an option/standard.

      • ⅔ of women were allocated to cesarean delivery, but 71% of those undergoing planned vaginal breech birth were successful. 

      • There was no difference in perinatal mortality/morbidity was noted between groups in this study – suggesting that rigorous protocols and assessment by those with experience may make breech birth safer.

Interesting critique of trial: https://www.ogmagazine.org.au/14/2-14/term-breech-trial/ 

Planned Home Birth


What is the history of home birth? 

  • Until recent history, the home was the place for birth! In fact, the term was not coined until the 19th century because until then, birth usually occurred at home and not in a birthing center or hospital.

    • In the United States, in 1900, close to 100% of births were at home 

    • In 1938, rates had fallen to 50%, and then fewer than 1% in 1955 

    • In other countries like the UK, the trend to non-home births was slower, but still occurred; IN the UK, 80% of births occurred at home in the 1920s, and only 1% in 1991 

    • In Japan, this happened much later: In 1950, 95% of births occurred at home, but only 1.2% in 1975 

    • However, recently between 2004-2009, the number of home births in the US increased by 41% 

  •  Where in the world are there still home births? 

    • Many countries! 

  • So why did home births decrease over the years?

    • Hard to know exactly why 

    • There is some increased medicalization of birth 

    • In the hospital, there was the promise of anesthesia – ie. you could get an epidural 

    • At the same time, there was a trend of decrease maternal mortality and morbidity as well as decreased infant morbidity 

Why is there an increased movement to home birth? 

  • One note 

    • We want to discuss planned home births, not unplanned ones! 

  • Lots of reasons 

    • Some birthing people like the familiar environment of their home, and do not like the medically centered birth experience 

    • Some people feel it is more relaxing at home 

    • In one study published in the Journal of Midwifery and Women’s Health the top five reasons were: 

      • Safety 

      • Avoidance of unnecessary medical interventions 

      • Previous negative hospital experiences 

      • More control 

      • Comfortable and familiar environments 

    • One other study found that women experienced pain differentially and less negatively in the home setting 

  • This speaks to some of the things that we in hospitals or even birth centers can do to make patients feel safer and more comfortable! 

    • Clearly, some patients do not feel safe in the hospital setting, even though as doctors, we would argue that the hospital is the “safest” place to deliver a baby because of quick access to resources (ie. blood banks, ORs, NICUs) 

    • So I think this study gives us a good way to figure out what we can do in the hospital to make patients feel more comfortable

    • See our episode on limiting interventions in birth! 

  • What about now? Where in the US is there increases in home birth?

    • Top five in 2020:

      • Idaho (3.2%) 

      • Vermont (3%) 

      • Wisconsin (2.8%) 

      • Montana (2.6%) 

      • Utah (2.6%) 

So, now that we know there is increased desire for home birth, what is the evidence for or against home birth? 

  • A word on the evidence

    • Our gold standard is of course to have a randomized controlled trial, but you really can’t do that ethically for home birth! 

    • So most data is from observational studies, but they are often limited by methodological problems, including small sample size, lack of appropriate control group, reliance on birth certificate data, reliance on voluntary submission of data or self-reporting, limited ability to distinguish accurately between planned and unplanned home births, and variations in skill, training, and certification of birth attendants etc.  

The data for home birth for moms 

  • Patients don’t want unnecessary interventions — and look at all the interventions we do!

  • Even in TOLACers it seems that we do a lot – maybe it’s safe to TOLAC at home  

    • In England, women planning a home trial of labor after cesarean exhibited fewer obstetric risk factors, more likely to deliver vaginally, and had similar maternal and perinatal outcomes compared with those planning hospital TOLAC 

The data against home birth for moms 

  • Most research about home birth cohorts recently have strict selection criteria for appropriate candidates

    • So remember: these studies usually select so that there is absence of preexisting maternal disease, absence of significant disease arising in pregnancy (so think of all your GDMs! Your hypertensives!), singleton fetus, cephalic presentation, gestational age >36 or 37 weeks and less than 41-42, labor is spontaneous 

  • Finally, while in many other countries they may have safe methods of identifying risk and reasons to get moms to the hospital, most places in the US do not have this 

    • The relatively low rates of morbidity and mortality reported for planned home births from Ontario, British Columbia, and the NEtherlands were from highly integrated health care systems with established criteria and provisions for emergency intrapartum transport 

    • In the US, however, the home birth attendant (midwife, etc) do not always have hospital privileges or are not connected to a doctor that has hospital privileges 

    • There is not a safe and timely way to transfer the patient intrapartum to the hospital if needed 

    • There is also a reported risk of needing intrapartum transport to hospital of 23-37% for nulliparous women and 4-10% for multiparous women 

    • Reasons for transport: lack of labor progress, nonreassuring fetal status, need for pain relief, hypertension, bleeding, and fetal malposition 

Conclusion: It does appear that home births can be safe for mom, but only in a selected populations. We would recommend that if someone desires to have a home birth, that they have a birth attendant that is a certified nurse midwife (CNM) or a physician who practices obstetrics within an integrated and regulated health system. They should also have a plan about when and how to come into the hospital if there are complications. 

They should also be a specifically selected population:

  • Absence of preexisting maternal disease 

  • Absence of significant disease during pregnancy 

  • Singleton fetus 

  • Cephalic presentation 

  • Term gestation, and not post dates 

  • Spontaneous labor 

  • No uterine scars (ie. no TOLAC) 

That data for home births for babies 

  • While we can see that in previous data, there was some increased risk of neonatal morbidity and mortality, there was a recent big paper that looked at 10,609 births that came out in the Green Journal in November 2021, published by midwives in Washington state 

  • https://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=2021&issue=11000&article=00002&type=Fulltext

  • Basically, they compared planned home births (40.9% of the population they studied) vs. planned birth center births (59.1%) 

    • Their results were really great! Not only did they have a C/S rate of 11.4% for the nulliparous women and 0.87% for the multiparous women, the perinatal mortality rate after onset of labor was 0.57/1000 (super low, compared even to older data)

    • Compared to planned birth center births, planned home births had similar risks in crude and adjusted analyses 

    • Overall, numbers were low anyway for 

  • The data against home births for babies 

    • That’s all well and good for Washington

    • But let’s not forget that these women were carefully selected for a planned home birth 

      • They followed ACOG’s guidelines 

      • If we look at the demographics, most of these women were <35 (only 21% were 35 or older) 

      • These women were thin (63% had normal BMIs, and only 14% had BMIs >30) 

      • Most of them were white (83.8%) 

      • They likely were of higher social class (62% had commercial insurance) 

      • Most of them were multiparous (63.9%, and 8.4% had >4 prior births) 

      • Only 3.2% had gestational diabetes

      • Basically, very healthy population that not all people fit the mold for 

    • There is a lot more increased perinatal morbidity for babies in other data! And mortality!

      • Basically: there is about a 2.43x risk of perinatal mortality if we look at all data and a 3x increase risk of neonatal seizures or serious neurological dysfunction 

      • Overall, yes these numbers are small (death is 1-2/1000 and seizures/neurological dysfunction is 0.4-0.6/1000)  

      • Even in this study from Washington state, nulliparous women had a 1.04/1000 birth perinatal mortality rate

Conclusions: Again everyone has the right to choose what type of birth they have. However, if we look at data as a whole, neonatal outcomes are overall worse with planned home births overall compared to in hospital births. While these outcomes are overall low, patients should still be counseled the risk of perinatal death is approximately 2x higher in planned home birth and neonatal seizures/neurological dysfunction is about 3x higher. It’s likely that these outcomes can be mitigated in the right population with a good plan to transfer patients/babies to a hospital and with the right birth attendant. 

However, the fact remains that there is not always infrastructure in place to make sure that all of these things can happen. 

Therefore, it’s important to discuss these studies with your patients and especially review with them if they are a good candidate or not. Remember they should also be a specifically selected population:

  • Absence of preexisting maternal disease 

  • Absence of significant disease during pregnancy 

  • Singleton fetus 

  • Cephalic presentation 

  • Term gestation, and not post dates 

  • Spontaneous labor 

  • No uterine scars (ie. no TOLAC) 

Mastitis

Here’s the RoshReview Question of the Week:

A 30-year-old woman presents to the office with right-sided breast swelling and pain. She is 8 weeks postpartum from a spontaneous vaginal delivery of a term infant and is currently breastfeeding. She states her right breast is very painful, swollen, and red, and she has had a fever for the last 2 days. Which one of the following is the most appropriate next step for this patient?

Check your answer and get a special discount at the link above!


For more on breastfeeding, see our prior breastfeeding episodes (Part I and Part II) with Dr. Erin Cleary 

Before we get into mastitis… Breastfeeding is challenging!

  • There are many benefits to breastfeeding

    • Decrease in breast cancer, ovarian cancer, diabetes, HTN, heart disease 

    • Recommendation for breastfeeding for first 6 months of life or longer 

    • Benefits to the infant as well 

  • However in the US, as high as 45% of women report early, undesired weaning

    • Can be because of many things; nipple pain, perception of low milk supply, difficulty with latch

    • Other social factors, ie. limited access to maternity leave, barriers to breastfeeding in the workplace  

    • Depression, previous negative breastfeeding experiences 

  • Also, many things can occur in breastfeeding that can be a challenge 

What can look like mastitis? 

  • Engorgement

  • Physiologic breast fullness that often occurs between day 3-5 postpartum 

  • Typically reassuring sign that mature milk is being secreted 

  • However, can cause symptoms of distention, pain, tenderness, firmness and even fever (usually lower fever) - which can make it easy to confuse with mastitis 

  • Slightly swollen and tender lymph nodes 

  • Can sometimes be very pronounced and there should be anticipatory guidance 

  • Treatment:

    • Overall, data on prevention is limited

    • Can try acupuncture, hot and cold packs, cabbage leaves - but all from systematic reviews have found insufficient evidence to recommend a particular treatment regimen 

    • Can use milk expression to relieve some symptoms 

  • Persistent breast pain with feeding

    • Can be caused by many things  

      • Nipple damage from baby or with overuse/misuse of pump

        • Infant with tight lingual frenulum “tongue tie” - can get frenotomy or frenectomy 

        • Can help observe pumping session and adjust level of suction or fit of flange with lactation consultants  

      • Psoriasis, eczematous conditions - need to apply emollient and reduce identifiable triggers 

      • Candida infections - topical azole and antifungal ointment or cream are ok, or even oral fluconazole 

      • Herpes simplex or zoster - can be seen a small, clustered tender vesicles

        • Treatment with oral antiviral therapy 

        • Stop breastfeeding on that side temporarily 

  • Galactocele - milk retention cyst 

    • Usually just a collection of fluid that is caused by obstructed milk duct - usually soft cystic masses 

https://creogsovercoffee.com/notes/2019/6/16/breastfeeding-part-ii-facts-and-myth-busting

  • Infant’s chest rests against maternal body

  • Infant’s chin touches the breast, tongue is down 

  • Lips flanged outward

  • Little or no areola is visualized 

  • Rhythmic sucking present 

  • Audible swallowing present

  • Latch is not uncomfortable or painful and nipple is not injured or misshapen after breastfeeding  

What is mastitis? 

  • Defined as inflammation of the breast 

    • Can occur spontaneously, but today we’re talking just about mastitis in the context of breastfeeding 

  • Can occur in about 10% of patients who are breastfeeding 

    • Is especially problematic because it can lead to discontinuation of breastfeeding 

  • Risk factors:

    • Infant attachment issues - ie. short frenulum, cleft lip/palate

    • Cracked nipples, local milk stasis 

    • Missed feedings 

    • Poor maternal nutrition 

    • Previous mastitis 

    • Primiparity

    • Use of breast pump 

    • Yeast infection 

  • Diagnosis

    • Usually is made clinically 

    • Presentation usually is:

      • Localized, unilateral breast tenderness + erythema 

      • Fever - usually high! >101.0F (38.5C)

      • Can also have malaise, fatigue, body aches, headache 

      • Rarely will need to have culture to identify organism 

    •  On exam: will find redness, tenderness on one aspect of a breast (can be in different quadrants)

      • Be sure to examine for fluctuance - is there an abscess?  

    • When to get imaging:

      • If you suspect abscess on physical exam 

      • If symptoms are not improving despite medical management 

      • Usually can diagnose via ultrasonography  

  • Treatment

    • Breastfeeding technique

      • Lactation consultation to improve technique 

      • Counsel that patient should not stop breastfeeding or pumping on that side, as stopping can lead to milk stasis and more likely to develop abscess 

      • Can continue breastfeeding!  

      • Usually, the baby is already colonized by the same organism 

    •  Medical management

      • Antibiotics are usually needed for 10-14 days

      • Possible treatments include:

        • Augmentin 875 mg BID 

        • Keflex 500 mg 4x/day (hard to do 4x/day meds) 

        • Clindamycin 300 mg 4x/day - can be used against MRSA 

        • Dicloxacillin 500 mg 4x/day 

        • Bactrim DS (160mg/800 mg) BID - can be used against MRSA, but usually may want to avoid in patients with preterm infants 

  • When to refer

    • Abscess

      • Usually needs to be drained 

      • Can often be done at the bedside, and usually will not need to refer to breast surgery if you feel comfortable 

      • However, can depend on individual provider’s level of comfort  

    •  Abnormal presentation/lack of response to treatment

      • Most mastitis should resolve after initial treatment, and recurrence is not common, but can result from inappropriate or incomplete antibiotic therapy 

      • Most abscesses do not recur 

      • Inflammatory breast cancer can resemble mastitis at times, but may be differentiated by skin thickening as well as axillary lymphadenopathy 

Postpartum Care

Here’s the RoshReview Question of the Week:

A 23-year-old G1P1001 woman presents to the office for her routine postpartum visit. She is 6 weeks postpartum status post vaginal delivery of a healthy infant. Her pregnancy was complicated by diet-controlled gestational diabetes mellitus and obesity. She completes a 2-hour glucose tolerance test using a 75 g glucose load. Her fasting plasma glucose level is 85 mg/dL, and her 2-hour plasma glucose level is 130 mg/dL. Which of the following is the most likely diagnosis?


More Reading: ACOG Committee Opinion 736 from May 2018: Optimizing Postpartum Care 

Why Do We Care About PP Care? 

  • The days/weeks following birth are critical for patient and infant well-being 

    • Multiple physical, social, and psychological changes 

    • Recovery from delivery (either vaginal or cesarean) 

    • Challenges of breastfeeding

    • Lack of sleep, fatigue, pain, stress

    • New or exacerbation to mental health disorders 

    • Urinary or even anal incontinence 

  • Challenges 

    • Fragmented care between pediatric and obstetric care providers: 

      • As an example of what babies get: day 1-2 of life, day 3-5 of life, 1 month check up, 2 month, 4 month, 6 month, 9 month, and 12 month 

      • Just for well babies! 

      • If other complications, maybe more visits! 

    • Long time before we see our patients 

      • Usually, will see them at 4-6 weeks postpartum 

      • Initial lack of attention to maternal health needs - more than half of pregnancy related deaths occur after the birth of the infant! 

      • Instead of ongoing care, we have fragmented, one or two time visits 

A Call to Action 

  • Because of these issues, ACOG has wanted to increase awareness for the fourth trimester 

  • What we currently have - (FYI, this is me ranting about our current system because I’m a raging socialist. Feel free to chop as much as needed) 

    • 4-6 week visit x1 

    • Edinburgh postpartum depression screens to try and catch postpartum blues, but administered in the hospital and again at 4-6 weeks - can miss depression in the first month after birth

    • With COVID, often not letting family members or infants come to postpartum visits 

    • All pregnant patients receive health insurance through Medicaid, but this insurance stops at 6 weeks postpartum 

    • The US is also one of 7 countries in the entire world without paid maternity leave (WTF) 

    • On average, countries that provide paid maternity leave pay 77% of previous pay 

    • The UK has paid maternity leave minimum of 39 weeks. Most places have a minimum paid maternity leave of 12 weeks to a full year, and on average, globally, the paid maternity leave is 29 weeks. Average paternity leave is 16 weeks 

NY Times

  • What this results in

    • Less attendance of postpartum visits

      • Not wanting to use accrued family leave/sick days for appointments 

      • Unable to find someone to care for themselves/their infants to go to appointments 

      • Results in as many as 40% of patients don’t go to postpartum visits 

      • 23% of employed women return to work within 10 days postpartum, and an additional 22% return to work between 10-40 days pp!!!!! 

    • Less anticipatory guidance

      • With decreased time during pregnancy (due to covid) and also with not going to postpartum visits and not having PP visits soon enough → on a national survey, less than ½ of patients attending a PPV reported the received enough info about depression, birth spacing, healthy eating, importance of exercise, changes to their sexual response and emotions 

      • In randomized controlled trial, 15 minutes of anticipatory guidance before discharge, followed by phone call at 2 weeks reduced symptoms of depression and increased breastfeeding duration through 6 months among black and hispanic women  

    • More maternal morbidity and mortality 

  • What we want (and ACOG wants) 

    • Timing of postpartum visit be individualized and woman centered 

    • Initial assessment within 3 weeks postpartum to address acute issues 

    • Follow this up with ongoing care as needed - ie. well woman visit no later than 12 weeks after birth 

    • Insurance should allow for this care (don’t take it away after 6 weeks!)

      • American Rescue Plan Act - allows states to extend Medicaid coverage for pregnant people from 60 days to 1 year postpartum 

      • As of 4/2022: currently in effect for 13 states 

      • 14 states and DC planning to implement a 12 month extension 

      • 4 states with limited overage extension approved or proposed 

      • 4 states pending legislation to seek federal approval 

What should we be doing then for PP Care? 

  • Start early - begin anticipatory guidance even in prenatal care! 

    • Develop a postpartum care plan (Table 1 - can go through some of these things) 

    • Reproductive life planning 

      • Review desire for future pregnancies 

      • Counsel pregnancy spacing (avoid short interval pregnancy, within 6 months, and risks and benefits of pregnancy sooner than 18 months) 

      • Review contraception options if desired 

    • Build a support system 

      • Review: who will provide social and material support? Ie. family, friends

        • Can get social work involved if needed  

      • Identify providers that patient can call with questions

        • Primary care provider, Ob provider, psychiatry provider 

        • Pediatric provider 

        • Lactation support 

        • Care coordinator/case manager 

        • Home visitation 

        • Provide phone numbers or other contact information  

  • Intrapartum to Postpartum Care

    1. Early postpartum period contains substantial morbidity 

    2. Blood pressure evaluation no later than 7-10 days postpartum for those with hypertension

      1. Great studies regarding postpartum blood pressure checks via text message - easy for both patients and clinicians

      2. Decreases usage of emergency rooms 

      3. Those with severe hypertension should be seen within 72 hours!  

    3.  In person follow up earlier for patients with complications such as: 

      1. Cesarean section or perineal wound infection 

      2. Lactation difficulties 

      3. Chronic conditions like seizures that may require postpartum medication titration 

    4. WHO recommends follow up of all women and infant dyads at 3 days, 1-2 weeks, and 6 weeks - we don’t do this in the US! 

    5. Based off of this ACOG recommends first contact within 3 weeks (does not have to be in person, can be by phone) 

    6. Can set up postpartum care either in the prenatal period (we will usually make pp appointments for patients in the hospital or right before delivery) 

  • The components of postpartum care - these were really good from ACOG, so thought I would include 

    1. Mood and emotional well-being 

    2. Infant care

    3. Sexuality, contraception, birth spacing 

    4. Sleep/fatigue 

    5. Physical recovery 

    6. Chronic disease management 

    7. Health maintenance 

What about birth trauma? 

  • Remember that trauma is in the eye of the beholder

    • Many healthcare providers may not even be aware that their patient experienced trauma 

    • Allow patients to ask questions about their labor, childbirth course and review any complications 

    • Complications should be reviewed and how they can best be avoided in next pregnancy if possible (ie. reduce risk of preterm birth, preeclampsia)  

    • Referral to support group, mental health care specialist 

  • Pregnancy loss 

    • Remember to always review someone’s labor course and delivery!

      • May sound basic, but there are times when people miss a cesarean scar or even that someone had a pregnancy loss and congratulate the patient (omg)  

    • Emotional support and bereavement counseling with referrals if appropriate 

    • Review labs and path from loss 

    • Order other labs if needed (look at our stillbirth episode) 

Transition to ongoing care 

  • Refer to ongoing well woman care within 12 weeks 

  • Make sure that there is a good transition for birth control/continued prescriptions

    • Write this out in your notes/recommendations 

    • Many patients all of a sudden don’t have access to get their birth control because their obstetrician or midwife isn’t seeing them anymore 

    • Or, if their OB started them on an antidepressant, all of a sudden, they don’t get scripts anymore because they are not longer postpartum - make sure to help patients get appointments to their PCP or mental health care and transition them!  

The ALPS Trial

The #OBGynInternChallenge is back! Enrollment will open Monday 4/18. Check out www.obgyninternchallenge.com/enroll.


Here’s the RoshReview Question of the Week:

A 21-year-old G1P0 woman at 36w2d gestation presents to L&D with preterm contractions. Which of the following is an indication for giving antenatal corticosteroids?

Check out the links above for the correct answer, and get more details on the group discount deal with RoshReview QBanks for CREOG and ABOG exam studying!


THE ALPS Study

Actual Title: Antenatal Betamethasone for Women at Risk for Late Preterm Delivery 

ALPS = Antenatal Late Preterm Steroids 

Some general background information 

  • Who did the study and who published it? 

    • Another study done by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, MFMU 

    • Published in the NEJM in 2016 

  • Why was the study done? 

    • Antenatal corticosteroids were widely used up to 34 weeks prior to this study 

    • Decided after consensus conference held by the National Institutes of Health in 1994 - strong evidence that corticosteroids reduce adverse neonatal outcomes (death, RDS, and other morbidities) 

    • Recommendation not given after 34 weeks because it was thought that babies usually do well after 34 weeks 

      • However, it became clear later that infants born in the late preterm period still have increased neonatal and childhood risks compared to term infants 

      • 8% of all deliveries occur in the late preterm time period 

  • Question we want answered: 

    • Does administration of betamethasone to women likely to deliver in the late preterm period (defined as 34w0d - 36w6d) decrease respiratory and other neonatal morbidities?

Methods 

  • Who participated and when? 

    • Done at 17 university-based clinical centers participating in the MFMU Network

    • Recruitment began in October 2010 - February 2015  

    • Eligibility criteria:

      • Live singleton pregnancy 34w0d- 36w5d 

      • High probability of delivery in the late preterm period

        • Preterm labor with intact membranes, at least 3 cm dilated or 75% effaced or

        • Spontaneous rupture of membranes 

        • If neither applied, expected preterm delivery for any other indication via IOL or CS between 24h - 7 days after planned randomization  

    •  Ineligible if: 

      • Expected to deliver in <12 hours for any reason

        • ROM with more than 6 contractions/hour or cervical dilation of 3 cm or more unless pit was withheld for at least 12 hours (but other induction agents were allowed) 

        • Chorioamnionitis 

        • Cervical dilation 8 cm or more 

        • Evidence of non-reassuring fetal status requiring immediate delivery  

      • Previously received steroids for fetal lung maturity in pregnancy  

      • Candidate for stress dose steroids 

      • Contraindication to betamethasone 

      • Pre-gestational diabetes 

      • Known major fetal anomaly 

  • How was the study done? 

    • After subjects were consented, they were allocated in 1:1 ratio to either course of 12 mg of BMZ (2 doses 24 hours apart) or placebo 

    • Stratified by clinical site and gestational age categories (34-35 weeks vs. 36 weeks) 

    • Double-blind (neither study participant nor investigator knew if BMZ or placebo)

    • Rest of labor/delivery managed per indication  

  • What outcomes did they look for?

    • Primary outcome 

      • Composite endpoint for need for respiratory support by 72 hours of age consisting of:

        • CPAP or HFNC for at least 2 consecutive hours 

        • O2 requirement with FiO2 of at least 30% for at least 4 continuous hours

        • ECMO or mechanical ventilation  

      •  Stillbirth and neonatal death before 72 hours were also included in both composite outcomes as they could be competing events 

      • Subgroup analysis for primary outcome and severe respiratory morbidity  for 34-35 vs 36 weeks gestation, indication for trial entry, planned CS vs planned VD, sex, and race/ethnicity 

    • Secondary outcomes 

      • Neonatal: many, but included severe respiratory morbidity; TTN, apnea, bronchopulmonary dysplasia, need for surfacntat, hypoglycemia, resuscitation, feeding difficulty, IVH, sepsis, death before discharge, etc.  

What were the results 

  • Who did they recruit?

    • Out of 24,538 screening, 2831 eligible were consented and randomized

      • 1429 got betamethasone 

        • Only 860 (60%) got both doses 

      • 1402 got placebo  - only 826 (59%) got both doses 

      • Reason those did not get a second dose: 95% delivered before 24 hours

  • What were their outcomes?

    • No stillbirths or neonatal deaths within 72 hours

    • 4 women lost to follow up (0.14%) 

    • Primary outcome: 

      • Occurred less frequently in the BMZ group than placebo 

        • 11.6% vs. 14.4% RR 0.8, 95% CI 0.66-0.97, p = 0.02 

        • Number needed treat to prevent one case was 35 

      • Unchanged in post-hoc analyses 

      • None of the subgroup analysis were significant 

    •   Secondary outcome 

      • Severe respiratory morbidity composite outcome also significantly reduced in BMZ compared to placebo

        • 8.1 vs. 12.1%, RR 0.67, 95% CI 0.53-0.84, P<0.001 

        • NNT 25 

        • Rate of TTN, need for resuscitation, and BPD were significantly less frequent in BMZ group  

      • No significant difference in chorio or endometritis 

    • Other findings of note: 

      • Significant difference in hypoglycemia of glucose <40

        • 343 (24.0%) vs 209 (14.9%) -  those that got BMZ more likely to have hypoglycemia, P<0.001 

What was the impact? 

  • Found that BMZ even up to 36w5d for initial can decrease respiratory morbidity 

  • Consistent with previous data from the ASTECs trial (Antenatal STeroids for Term Cesarean Section)

    • This did find dec NICU admission for respiratory distress

    • So babies in the UK do get steroids at term for CS not in labor!  

  • There is a recommendation from ACOG now to give single course of steroids to pregnant patients between 34w0d-36w6d at risk of preterm delivery within 7 days who have not previously received steroids